VHC

VirnetX has completed its metamorphosis from a patent-licensing entity into a pre-revenue cybersecurity vendor, and the numbers show a company at the very beginning — not the payoff — of that journey. FY2025 revenue was $162K. The 3,140% 'growth' is an artifact of a $5K base; in absolute terms the company sells essentially nothing while carrying a $52.3M market cap, a P/S of 323x. Against that sits a $18.2M net loss (identical to FY2024), a -12,000% operating margin, and $15.6M of operating cash burned in the year. This is not a business yet; it is an R&D project ($5.65M) wrapped around a DoD/ZTNA product roadmap (VirnetX One, Matrix, War Room) that the MD&A itself frames in aspirational, forward-looking language — 'intend to,' 'developing,' 'undertaken efforts,' 'we believe' — with no signed revenue to point to.

The balance sheet turns aspiration into urgency. Cash fell 33% to $15.5M while the company burned $15.6M in operations — roughly one year of runway at the current pace. Total assets dropped 37% and equity 43% in a single year; the accumulated deficit is $222.9M, which the 10-K flags directly alongside back-to-back $18.2M losses and explicit doubt about ever 'achieving or sustaining profitability.' With only 4.19M shares (the -$5.00 diluted EPS implies a heavy prior reverse split), any capital raise to bridge the runway would be sharply dilutive at these levels. Low liabilities (0.38x equity) are the one bright spot, but they don't offset a self-funded cash bleed against a shrinking cash pile.